New Companies
Filter News
Found 4,157 articles
-
Cambrian BioPharma Unveils New Pipeline Company - Isterian Biotech
1/12/2023
Cambrian BioPharma , a multi-asset longevity biotech, today unveils its latest pipeline company, Isterian Biotech.
-
ATP and NYU Langone Health Launch Aethon Therapeutics to Eradicate Drug-Resistant Cancer Cells
1/9/2023
New therapies targeting oncogenic mutations in proteins such as RAS and EGFR hold great promise for people fighting cancer.
-
Opticyte Earns FDA Breakthrough Device Designation for the First Cell O2 Patient Monitor for Organ Failure
1/9/2023
Opticyte Earns FDA Breakthrough Device Designation for the First Cell O 2 Patient Monitor for Organ Failure.
-
Carmot Therapeutics Launches Spin-Off, Kimia Therapeutics, to Focus on Metabolic Disease
1/5/2023
Carmot Therapeutics, Inc. today announced its intent to spin off its Chemotype Evolution (CE) discovery platform in the fields of oncology, immunology and inflammation, to a separate and new company, Kimia Therapeutics (Kimia).
-
Belharra Launches with $130M From Versant, Genentech to Advance Chemoproteomics Platform (Updated)
1/4/2023
Backed by Versant and Genentech, Belharra Therapeutics launched Wednesday with $130 million in total financing to advance its novel chemoproteomics platform. -
Belharra Therapeutics Debuts With $130 Million in Funding
1/4/2023
Belharra Therapeutics, Inc. today emerged from stealth mode with a novel photoaffinity-based chemoproteomics platform capable of identifying non-covalent, small molecule drug candidates for any protein.
-
AppScent, A new Israeli Start-Up, invented a revolutionary medical device solves sleep apnea disorder that risks hundreds of millions around the globe
12/19/2022
A new development made by AppScent, an Israeli Start-Up company, is going to end the need to deal with the dangerous consequence of sleep apnea symptoms, that causes suffer to millions of people.
-
Covalent biologic company Enlaza launches with $61M in seed financing.
-
Endonovo Announces Plans for Spin-off of Medical IP and Assets
12/15/2022
Endonovo Therapeutics, Inc. announced plans to affect a spin-off of its medical device assets to a new company being formed by its current President and Chief Commercial Officer of its Medical Division, Ira Weisberg.
-
Flagship-Backed Biotech Uses Naturally-Occurring Molecules to Treat Chronic Disease (Updated)
12/13/2022
Flagship Pioneering has committed $50 million to Montai Health, a biotech that aims to develop therapies for chronic diseases using molecules already found in nature. -
Black Diamond Therapeutics Announces Spinout of Launchpad Therapeutics, Inc., an Antibody-Focused Precision Oncology Company
12/12/2022
Black Diamond Therapeutics, Inc. today announced the formation of Launchpad Therapeutics, Inc.
-
Yaral Pharma Launches in the US
12/12/2022
Yaral Pharma Inc., the US generics subsidiary of IBSA, a long-standing, multinational pharmaceutical company headquartered in Lugano, Switzerland, launched with the mission of providing access to high quality, affordable, authorized generics and complex generic medicines to enhance healthcare outcomes.
-
With $47 million in hand, Dantari launched Thursday to advance its Targeted High-capacity Drug Conjugate technology – its take on an antibody-drug conjugate - for solid tumors.
-
GenScript Partners with Allozymes to Accelerate Protein Discovery and Target Identification
12/7/2022
GenScript Biotech Corporation, the world's leading provider of life-science research tools and services, is partnering with Allozymes, a Singapore-based biotech startup, to dramatically accelerate the enzyme discovery and development process.
-
Paragon Therapeutics Launches First Spinout, Apogee Therapeutics, to Advance Novel Therapies for Inflammatory and Immunological Conditions
12/7/2022
Paragon Therapeutics today announced the launch of Apogee Therapeutics, LLC, its first spinout.
-
Entact Bio launched with $81 million Tuesday to advance its protein enhancement platform.
-
SonoThera closed its Series A round of financing Monday, counting $60.75 million in earnings and will use these proceeds to advance its ultrasound-guided, non-viral gene therapy platform.
-
AnPac Announces Strategic Initiative to Establish A Wholly-Owned Subsidiary for US Food Market
12/5/2022
AnPac Bio-Medical Science Co., Ltd. announced that the Company has formed a wholly-owned subsidiary Fresh2 Technology Inc in the State of Delaware on October 4, 2022 in order to establish the company's new product line of business-to-business food trade and delivery platform for local restaurants and supermarkets, a combination of the China’s food distribution strategies and North America’s growing Asian food market.
-
PictorLabs emerged from stealth mode Thursday with $18.8 million to advance its AI-powered virtual staining platform that researchers hope will “reimagine the future” of histopathology.
-
Enveric Biosciences Announces Confidential Submission of Registration Statement for the Spin-off of its Cannabinoid Business to Shareholders
11/28/2022
The proposed spin-off would create two separate and distinct biotechnology companies, one developing next-generation psychedelic-inspired treatments and the other developing innovative cannabinoid treatments.